Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells.

Ugolini S, Arpin C, Anfossi N, Walzer T, Cambiaggi A, Förster R, Lipp M, Toes RE, Melief CJ, Marvel J, Vivier E.

Nat Immunol. 2001 May;2(5):430-5. Erratum in: Nat Immunol 2001 Jul;2(7):658.

PMID:
11323697
2.

Modulation of T-cell functions in KIR2DL3 (CD158b) transgenic mice.

Cambiaggi A, Darche S, Guia S, Kourilsky P, Abastado JP, Vivier E.

Blood. 1999 Oct 1;94(7):2396-402.

PMID:
10498612
3.

The enigma of activating isoforms of ITIM-bearing molecules.

Cambiaggi A, Lucas M, Vivier E, Vély F.

Curr Top Microbiol Immunol. 1999;244:169-76. Review. No abstract available.

PMID:
10453659
4.

Dependence of T cell antigen recognition on the dimensions of an accessory receptor-ligand complex.

Wild MK, Cambiaggi A, Brown MH, Davies EA, Ohno H, Saito T, van der Merwe PA.

J Exp Med. 1999 Jul 5;190(1):31-41.

5.

Engagement of natural cytotoxicity programs regulates AP-1 expression in the NKL human NK cell line.

Bernard K, Cambiaggi A, Guia S, Bertucci F, Granjeaud S, Tagett R, N'Guyen C, Jordan BR, Vivier E.

J Immunol. 1999 Apr 1;162(7):4062-8.

6.

Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases.

Le Dréan E, Vély F, Olcese L, Cambiaggi A, Guia S, Krystal G, Gervois N, Moretta A, Jotereau F, Vivier E.

Eur J Immunol. 1998 Jan;28(1):264-76. Erratum in: Eur J Immunol 1998 Mar;28(3):1122.

7.

Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor.

Cambiaggi A, Verthuy C, Naquet P, Romagné F, Ferrier P, Biassoni R, Moretta A, Moretta L, Vivier E.

Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8088-92.

8.

Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells.

Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E.

J Immunol. 1997 Jun 1;158(11):5083-6.

PMID:
9164921
9.

Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs.

Bléry M, Delon J, Trautmann A, Cambiaggi A, Olcese L, Biassoni R, Moretta L, Chavrier P, Moretta A, Daëron M, Vivier E.

J Biol Chem. 1997 Apr 4;272(14):8989-96.

10.

Inhibitory and activatory receptors for MHC class I molecules.

Cambiaggi A, Vivier E, Olcese L.

Res Immunol. 1997 Mar-Apr;148(3):172-9. Review. No abstract available.

PMID:
9255870
11.

Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes.

Renard V, Cambiaggi A, Vély F, Bléry M, Olcese L, Olivero S, Bouchet M, Vivier E.

Immunol Rev. 1997 Feb;155:205-21. Review.

PMID:
9059896
12.

Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases.

Olcese L, Lang P, Vély F, Cambiaggi A, Marguet D, Bléry M, Hippen KL, Biassoni R, Moretta A, Moretta L, Cambier JC, Vivier E.

J Immunol. 1996 Jun 15;156(12):4531-4.

PMID:
8648092
13.

Development in vitro of human CD4+ thymocytes into functionally mature Th2 cells. Exogenous interleukin-12 is required for priming thymocytes to produce both Th1 cytokines and interleukin-10.

Mingari MC, Maggi E, Cambiaggi A, Annunziato F, Schiavetti F, Manetti R, Moretta L, Romagnani S.

Eur J Immunol. 1996 May;26(5):1083-7.

PMID:
8647171
14.

The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.

Cambiaggi A, Orengo AM, Meazza R, Sforzini S, Tazzari PL, Lauria F, Raspadori D, Zambello R, Semenzato G, Moretta L, Ferrini S.

Blood. 1996 Mar 15;87(6):2369-75.

PMID:
8630400
15.
16.

HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells.

Mingari MC, Vitale C, Schiavetti F, Cambiaggi A, Bertone S, Zunino A, Ponte M.

Chem Immunol. 1996;64:135-45. Review. No abstract available.

PMID:
8942077
17.

In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.

Negri DR, Tosi E, Valota O, Ferrini S, Cambiaggi A, Sforzini S, Silvani A, Ruffini PA, Colnaghi MI, Canevari S.

Br J Cancer. 1995 Oct;72(4):928-33.

18.
20.

T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.

Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC, Moretta L.

Eur J Immunol. 1994 Oct;24(10):2294-8.

PMID:
7925558
21.

Characterization of a cyclosporin A-sensitive activation pathway in cultured T and natural killer cells.

Cantoni C, Cambiaggi A, Sforzini S, Poggi A, Viale M, Biassoni R, Ferrini S.

Scand J Immunol. 1994 Apr;39(4):373-9.

PMID:
8146596
22.

The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes.

Ferrini S, Sforzini S, Cambiaggi A, Poggi A, Meazza R, Canevari S, Colnaghi MI, Moretta L.

Int J Cancer. 1994 Mar 15;56(6):846-52.

PMID:
7907079
23.

Targeting of T lymphocytes against EGF-receptor+ tumor cells by bispecific monoclonal antibodies: requirement of CD3 molecule cross-linking for T-cell activation.

Ferrini S, Cambiaggi A, Sforzini S, Marciano S, Canevari S, Mezzanzanica D, Colnaghi MI, Grossi CE, Moretta L.

Int J Cancer. 1993 Dec 2;55(6):931-7.

PMID:
8253530
24.

Cultured human NK cells express the Ki-1/CD30 antigen.

Cambiaggi A, Cantoni C, Marciano S, De Totero D, Pileri S, Tazzari PL, Stein H, Ferrini S.

Br J Haematol. 1993 Oct;85(2):270-6.

PMID:
8280600
25.

Human CD3-CD16+ natural killer cells express the hGATA-3 T cell transcription factor and an unrearranged 2.3-kb TcR delta transcript.

Biassoni R, Verdiani S, Cambiaggi A, Romeo PH, Ferrini S, Moretta L.

Eur J Immunol. 1993 May;23(5):1083-7.

PMID:
8386664
26.

Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells.

Ferrini S, Cambiaggi A, Sforzini S, Canevari S, Mezzanzanica D, Colnaghi MI, Moretta L.

Cancer Detect Prev. 1993;17(2):295-300.

PMID:
8402715
27.

Induction of anti-tumor immune response by bispecific monoclonal antibodies (bimAbs).

Ferrini S, Cantoni C, Cambiaggi A, Chen Q, Venzano P, Canevari S, Colnaghi MI, Moretta L.

Pharmacol Res. 1992 Sep;26 Suppl 2:146-7. No abstract available.

PMID:
1409285
28.

Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules.

Ferrini S, Cambiaggi A, Cantoni C, Canevari S, Mezzanzanica D, Colnaghi MI, Moretta L.

Int J Cancer Suppl. 1992;7:15-8. Review.

PMID:
1428398
31.
32.

[Althesin in surgery of the eyeball].

Minola GC, De Bellis P, Cambiaggi A.

Minerva Anestesiol. 1980 Feb;46(2):219-28. Italian.

PMID:
7453989
33.

[Sympathetic ophthalmia with onset after a long interval following 2 successive eye injuries].

Cambiaggi A.

Pathologica. 1976 Jul-Aug;68(981-982):361-4. Italian. No abstract available.

PMID:
1018991
34.

[Retinal central artery occlusion, sign of asymptomatic thrombosis of the internal carotid].

Agnoli A, Cabella G, Cambiaggi A, De Carolis V.

Rev Otoneuroophtalmol. 1970 Dec;42(8):487-92. French. No abstract available.

PMID:
5510652
35.

[Heredofamilial aspects of lattice degeneration of the retina].

Cambiaggi A.

Boll Ocul. 1969 Jan;48(1):36-45. Italian. No abstract available.

PMID:
5371693
36.

The axial length of the eye of normal subjects and of patients with retinal detachment.

Grignolo A, Cambiaggi A, Rivara A.

Bibl Ophthalmol. 1969;79:118-27. No abstract available.

PMID:
5346731
37.

[On the effectiveness of combined therapy with a polysulpho-ester of xylan (Fibrase) and dextran (Macrodex) in vascular occlusions of the retina].

Cambiaggi A, Magnasco A, Sanna G.

Ann Ottalmol Clin Ocul. 1968 Apr;94(4):349-55. Italian. No abstract available.

PMID:
5708189
38.

[Research on the role of myopic chorioretinal changes in the pathogenesis of retinal detachment].

Cambiaggi A.

Ophthalmologica. 1968;156(2):124-32. French. No abstract available.

PMID:
5675132
39.

[Indirect binocular ophthalmoscopy and retinal angiography with fluorescence].

Cambiaggi A.

Boll Ocul. 1967 Oct;46(10):759-64. Italian. No abstract available.

PMID:
5605852
40.

[Considerations on various types of therapy of occlusion of the central retinal vein].

Cambiaggi A, Giacca S, Lepori R.

Minerva Oftalmol. 1966 Sep-Oct;8(5):164-72. Italian. No abstract available.

PMID:
5991428
41.

[Comparative research on behavior of the vitreous body, retina and vitreo-retinal relationships in both eyes of subjects with mono-ocular retinal detachment].

Cambiaggi A, Sanna G, Nervi I.

Ann Ottalmol Clin Ocul. 1965 Aug;91(8):679-88. Italian. No abstract available.

PMID:
5857842
42.

[Contribution to the knowledge of lattice degeneration of the retina; its relations with myopia and retinal detachment].

Cambiaggi A, Sanna G, Nervi I.

Ann Ottalmol Clin Ocul. 1965 May;91(5):314-21. Italian. No abstract available.

PMID:
5869402
43.

[OCULAR ASPECTS OF TOXOPLASMOSIS].

GRIGNOLO A, CAMBIAGGI A.

G Mal Infett Parassit. 1965 Apr;17:217-25. Italian. No abstract available.

PMID:
14321334
44.

[Incidence of diabetic retinopathy in relation to various types of antidiabetic therapy].

Cambiaggi A, Nervi I.

Ann Ottalmol Clin Ocul. 1965 Apr;91(4):242-52. Italian. No abstract available.

PMID:
5868689
45.

[CHOICE OF THERAPY OF OCCLUSION OF THE CENTRAL RETINAL VEIN IN RELATION TO CARDIOCIRCULATORY CONDITIONS].

CAMBIAGGI A, LEPORI R.

Boll Ocul. 1964 Oct;43:667-79. Italian. No abstract available.

PMID:
14314406
46.

MYOPIA AND RETINAL DETACHMENT: STATISTICAL STUDY OF SOME OF THEIR RELATIONSHIPS.

CAMBIAGGI A.

Am J Ophthalmol. 1964 Oct;58:642-50. No abstract available.

PMID:
14218174
47.

[FINDINGS ON RELATIONS BETWEEN DIABETIC RETINOPATHY AND DYNAMICS OF THE ACQUEOUS HUMOR].

CAMBIAGGI A, NERVI I.

Ann Ottalmol Clin Ocul. 1964 Aug;90:426-32. Italian. No abstract available.

PMID:
14229571
48.

[INFLUENCE OF THE POSITION OF THE BODY ON RETINAL ARTERY PRESSURE IN SUBJECTS WITH CAROTID OCCLUSION].

CAMBIAGGI A.

Riv Otoneurooftalmol. 1963 Nov-Dec;38:545-61. Italian. No abstract available.

PMID:
14112623
49.
50.

[Behavior of retinal arterial pressure in normal subjects following changes of body position].

CAMBIAGGI A, PASTINE G.

Riv Otoneurooftalmol. 1962 Sep-Oct;37:514-26. Italian. No abstract available.

PMID:
14017987

Supplemental Content

Loading ...
Support Center